151 related articles for article (PubMed ID: 24997381)
1. Consequences of ADHD medication use for children's outcomes.
Dalsgaard S; Nielsen HS; Simonsen M
J Health Econ; 2014 Sep; 37():137-51. PubMed ID: 24997381
[TBL] [Abstract][Full Text] [Related]
2. Social adversity and regional differences in prescribing of ADHD medication for school-age children.
Wallach-Kildemoes H; Skovgaard AM; Thielen K; Pottegård A; Mortensen LH
J Dev Behav Pediatr; 2015 Jun; 36(5):330-41. PubMed ID: 25997081
[TBL] [Abstract][Full Text] [Related]
3. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
[TBL] [Abstract][Full Text] [Related]
4. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
[TBL] [Abstract][Full Text] [Related]
5. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
[TBL] [Abstract][Full Text] [Related]
6. Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.
Brinker A; Mosholder A; Schech SD; Burgess M; Avigan M
J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):328-33. PubMed ID: 17630866
[TBL] [Abstract][Full Text] [Related]
7. Influence of Age, Gender, and Living Circumstances on Patterns of Attention-Deficit/Hyperactivity Disorder Medication Use in Children and Adolescents With or Without Intellectual Disabilities.
Osunsanmi S; Turk J
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):828-834. PubMed ID: 26982546
[TBL] [Abstract][Full Text] [Related]
8. ADHD Drug Prescribing Trend Is Increasing Among Children and Adolescents in Hong Kong.
Man KKC; Ip P; Hsia Y; Chan EW; Chui CSL; Lam MPS; Wong WHS; Chow CB; Yung A; Wong ICK
J Atten Disord; 2017 Dec; 21(14):1161-1168. PubMed ID: 24994875
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
10. Current Australian pediatric practice in the assessment and treatment of ADHD.
Efron D; Davies S; Sciberras E
Acad Pediatr; 2013; 13(4):328-33. PubMed ID: 23830018
[TBL] [Abstract][Full Text] [Related]
11. Physician practices to prevent ADHD stimulant diversion and misuse.
Colaneri N; Keim S; Adesman A
J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697
[TBL] [Abstract][Full Text] [Related]
12. The dramatic rise in neuroleptic use in children: why do we do it and what does it buy us? Theories from inpatient data 1988-2010.
Carlson GA
J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):144-7. PubMed ID: 23607407
[No Abstract] [Full Text] [Related]
13. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
[TBL] [Abstract][Full Text] [Related]
14. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.
Pottegård A; Bjerregaard BK; Glintborg D; Kortegaard LS; Hallas J; Moreno SI
Eur J Clin Pharmacol; 2013 Mar; 69(3):589-98. PubMed ID: 22811260
[TBL] [Abstract][Full Text] [Related]
15. Prescribing for ADHD in primary care.
Rashid A; Llanwarne N; Lehman R
Br J Gen Pract; 2018 Apr; 68(669):170-171. PubMed ID: 29592923
[No Abstract] [Full Text] [Related]
16. Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.
Štuhec M; Locatelli I; Švab V
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):254-9. PubMed ID: 25803789
[TBL] [Abstract][Full Text] [Related]
17. Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates.
Brownell MD; Yogendran MS
Can J Psychiatry; 2001 Apr; 46(3):264-72. PubMed ID: 11320681
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Age Children: Child and Adolescent Psychiatrists' Adherence to Clinical Practice Guidelines.
Chung J; Tchaconas A; Meryash D; Adesman A
J Child Adolesc Psychopharmacol; 2016 May; 26(4):335-43. PubMed ID: 27105063
[TBL] [Abstract][Full Text] [Related]
19. Telepsychiatrists' Medication Treatment Strategies in the Children's Attention-Deficit/Hyperactivity Disorder Telemental Health Treatment Study.
Rockhill CM; Tse YJ; Fesinmeyer MD; Garcia J; Myers K
J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):662-671. PubMed ID: 26258927
[TBL] [Abstract][Full Text] [Related]
20. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales.
Salmelainen P
N S W Public Health Bull; 2002 Jan; 13 Suppl 1():1-65. PubMed ID: 12189396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
